Why Have Veterinary Prices Been in the News?
Veterinary pricing in the UK has come under renewed scrutiny following the release of the Competition and Markets Authority (CMA) report into the veterinary sector.
The report highlights concerns around pricing transparency, ownership structures, and how easily pet owners can access alternative options for treatment and medication.
While veterinary care remains highly regulated and clinically driven, the CMA findings have brought increased attention to how services are priced — particularly for long-term conditions requiring ongoing medication.
What did the CMA report find?
The CMA identified several key areas contributing to rising costs and reduced transparency within the veterinary sector:
- Limited visibility of pricing before treatment
- Low awareness among pet owners of their right to request written prescriptions
- Increasing consolidation of veterinary practices under large corporate groups
- Potential conflicts between clinical care and commercial structures
These factors can make it difficult for owners to compare options or fully understand the cost of ongoing care.
In-Practice vs Corporate Online vs Independent Online Suppliers
One of the most visible outcomes of these structural differences is the variation in medicine pricing.
The same veterinary medicine may be priced differently depending on where it is supplied — whether directly through a veterinary practice, a large corporate online supplier, or an independent vet-led supplier.
These differences reflect variations in business models, purchasing power, infrastructure, and supply chains — rather than differences in the medicines themselves.
Why is pricing variation now under scrutiny?
The CMA report has brought attention to how veterinary services are structured — particularly the role of large corporate ownership groups that operate both veterinary practices and medicine supply chains.
In some cases, this vertical integration can reduce price competition and limit transparency for pet owners.
At the same time, many owners remain unaware that they have the legal right to request a written prescription and obtain medication from a registered UK supplier.
This combination of limited awareness and structural complexity has contributed to the current focus on veterinary pricing.
Are Online Pet Medicines Safe?
Yes — when supplied through a registered UK supplier.
All prescription veterinary medicines (POM-V) are regulated by the Veterinary Medicines Directorate (VMD). Medicines must be sourced, stored, and supplied in accordance with UK regulatory requirements.
Price differences do not indicate counterfeit or lower-quality products when medicines are sourced through legitimate UK supply chains.
Why Are Medicines Often More Expensive at Veterinary Practices?
A veterinary practice provides far more than medication supply. It delivers clinical care, including:
- 24/7 staffing and emergency cover
- Surgical and diagnostic facilities
- On-site monitoring and treatment
- Immediate access to medicines
- Responsibility for stock holding and expiry risk
These operational costs are reflected in pricing structures.
Why Do Prices Differ Between Online Suppliers?
Online suppliers operate under different models, which can influence pricing:
- Large corporate suppliers may benefit from national-scale purchasing agreements
- Independent suppliers may operate leaner models with lower fixed overheads
- Different supply chain strategies and stock handling approaches
These factors contribute to price variation across the market.
What About Pharmaceutical Rebates?
In both human and veterinary medicine, manufacturers may offer volume-based incentives to large purchasing groups.
These arrangements are based on scale rather than clinical factors. Importantly, they do not affect medicine quality, which is regulated independently through the VMD.
Prescription Medicines and Owner Choice
In the UK, pet owners have the legal right to request a written prescription and obtain medication from a registered UK supplier.
This system is designed to support transparency and allow owners to make informed decisions about their pet’s care.
What does this mean for pet owners?
The CMA report has increased awareness of how veterinary care is structured and priced in the UK.
For owners managing long-term conditions, understanding how prescriptions, supply routes, and pricing models work can make a meaningful difference over time.
Veterinary care remains essential and highly regulated, but improved transparency may help owners better navigate their options.
A changing landscape in veterinary care
The veterinary sector is evolving, with increasing focus on transparency, competition, and access.
As awareness grows, pet owners are likely to see more clarity around pricing and greater flexibility in how treatment and medication are accessed — while maintaining the same regulatory standards for safety and quality.